Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 825 of 1048 entries
View as:

Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER)

Phase: N/A Priority: Normal
NCT ID: NCT05976152 Org: User:
Start: 04/30/24 End: 12/31/26 Due: 12/31/27

Observational Study of Dydrogesterone in Cycle Regularization

Phase: N/A Priority: Normal
NCT ID: NCT02029144 Org: User:
Start: 12/31/13 End: 02/28/15 Due: 02/28/16

PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06156878 Org: User:
Start: 08/01/22 End: 08/31/25 Due: 08/31/26

UEMR Versus HSP in the Treatment of Pedunculated Colorectal Polyps Less Than 10mm in Size

Phase: N/A Priority: Normal
NCT ID: NCT06996522 Org: User:
Start: 06/01/25 End: 07/31/27 Due: 07/31/28

Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03541863 Org: User:
Start: 10/10/17 End: 12/20/18 Due: 12/20/19

NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens

Phase: N/A Priority: Normal
NCT ID: NCT06331520 Org: User:
Start: 05/01/24 End: 05/01/26 Due: 05/01/27

Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT01033578 Org: User:
Start: 10/31/99 End: 12/31/10 Due: 12/31/11

Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC

Phase: N/A Priority: Normal
NCT ID: NCT04912882 Org: User:
Start: 06/15/21 End: 12/01/25 Due: 12/01/26

Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT02039518 Org: User:
Start: 12/31/13 End: 06/30/17 Due: 06/30/18

The Efficacy and Safety of Anticoagulation in Chinese Patients With Non-ST Segment Elevation Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01271101 Org: User:
Start: 07/31/10 End: 08/31/11 Due: 08/31/12

PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCC

Phase: N/A Priority: Normal
NCT ID: NCT04974281 Org: User:
Start: 01/01/21 End: 12/31/22 Due: 12/31/23

Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03929094 Org: User:
Start: 03/01/19 End: 12/31/21 Due: 12/31/22

GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04979663 Org: User:
Start: 12/01/20 End: 06/30/22 Due: 06/30/23

Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06314334 Org: User:
Start: 03/04/23 End: 12/30/28 Due: 12/30/29

PET-CT Predicting Segement Specific Lymph Nodes Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT05970913 Org: User:
Start: 11/01/23 End: 12/01/24 Due: 12/01/25

Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1

Phase: N/A Priority: Normal
NCT ID: NCT02605265 Org: User:
Start: 10/31/15 End: 12/31/20 Due: 12/31/21

Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia

Phase: N/A Priority: Normal
NCT ID: NCT01503801 Org: User:
Start: 05/31/11 End: 12/31/12 Due: 12/31/13

Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients

Phase: N/A Priority: Normal
NCT ID: NCT06427291 Org: User:
Start: 09/21/23 End: 12/31/25 Due: 12/31/26

Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04582981 Org: User:
Start: 09/28/20 End: 12/31/23 Due: 12/31/24

CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC

Phase: N/A Priority: Normal
NCT ID: NCT03725254 Org: User:
Start: 10/20/18 End: 10/01/24 Due: 10/01/25

Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05098847 Org: User:
Start: 10/29/21 End: 10/30/25 Due: 10/30/26

The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03047811 Org: User:
Start: 08/26/16 End: 12/31/17 Due: 12/31/18

Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT04491682 Org: User:
Start: 09/01/20 End: 06/20/22 Due: 06/20/23

ORIENT-31 Regimen in Combination with SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs

Phase: N/A Priority: Normal
NCT ID: NCT06775743 Org: User:
Start: 01/31/25 End: 06/30/27 Due: 06/30/28

Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04707118 Org: User:
Start: 02/23/21 End: 12/30/22 Due: 12/30/23